Bradley Canino
Stock Analyst at Stifel
(1.16)
# 3,603
Out of 4,884 analysts
89
Total ratings
29.63%
Success rate
-11.08%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Bradley Canino
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BDTX Black Diamond Therapeutics | Maintains: Buy | $16 → $15 | $2.58 | +481.40% | 5 | Mar 7, 2025 | |
| ALXO ALX Oncology Holdings | Maintains: Hold | $3 → $1.5 | $0.46 | +226.02% | 8 | Mar 7, 2025 | |
| RLAY Relay Therapeutics | Maintains: Buy | $27 → $23 | $3.63 | +533.61% | 5 | Feb 27, 2025 | |
| ARVN Arvinas | Maintains: Buy | $63 → $51 | $7.95 | +541.51% | 6 | Feb 12, 2025 | |
| JANX Janux Therapeutics | Maintains: Buy | $70 → $115 | $24.45 | +370.35% | 2 | Dec 3, 2024 | |
| SNDX Syndax Pharmaceuticals | Maintains: Buy | $40 → $41 | $9.00 | +355.56% | 5 | Oct 14, 2024 | |
| KURA Kura Oncology | Downgrades: Hold | $26 → $19 | $5.86 | +224.23% | 6 | Oct 14, 2024 | |
| CELC Celcuity | Maintains: Buy | $39 → $42 | $13.79 | +204.57% | 4 | Oct 7, 2024 | |
| SMMT Summit Therapeutics | Maintains: Buy | $25 → $40 | $24.55 | +62.93% | 4 | Sep 25, 2024 | |
| NUVL Nuvalent | Maintains: Buy | $115 → $135 | $80.48 | +67.74% | 4 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $10.80 | +85.19% | 1 | Sep 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.10 | +809.09% | 1 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $10 | $1.26 | +693.65% | 17 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $99 | $53.82 | +83.95% | 7 | Jun 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $1.48 | +845.95% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $7.81 | +412.16% | 1 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $120 → $130 | $128.35 | +1.29% | 5 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $55 | $44.79 | +22.80% | 4 | Feb 23, 2024 |
Black Diamond Therapeutics
Mar 7, 2025
Maintains: Buy
Price Target: $16 → $15
Current: $2.58
Upside: +481.40%
ALX Oncology Holdings
Mar 7, 2025
Maintains: Hold
Price Target: $3 → $1.5
Current: $0.46
Upside: +226.02%
Relay Therapeutics
Feb 27, 2025
Maintains: Buy
Price Target: $27 → $23
Current: $3.63
Upside: +533.61%
Arvinas
Feb 12, 2025
Maintains: Buy
Price Target: $63 → $51
Current: $7.95
Upside: +541.51%
Janux Therapeutics
Dec 3, 2024
Maintains: Buy
Price Target: $70 → $115
Current: $24.45
Upside: +370.35%
Syndax Pharmaceuticals
Oct 14, 2024
Maintains: Buy
Price Target: $40 → $41
Current: $9.00
Upside: +355.56%
Kura Oncology
Oct 14, 2024
Downgrades: Hold
Price Target: $26 → $19
Current: $5.86
Upside: +224.23%
Celcuity
Oct 7, 2024
Maintains: Buy
Price Target: $39 → $42
Current: $13.79
Upside: +204.57%
Summit Therapeutics
Sep 25, 2024
Maintains: Buy
Price Target: $25 → $40
Current: $24.55
Upside: +62.93%
Nuvalent
Sep 16, 2024
Maintains: Buy
Price Target: $115 → $135
Current: $80.48
Upside: +67.74%
Sep 6, 2024
Initiates: Buy
Price Target: $20
Current: $10.80
Upside: +85.19%
Aug 8, 2024
Initiates: Buy
Price Target: $10
Current: $1.10
Upside: +809.09%
Jun 18, 2024
Maintains: Buy
Price Target: $32 → $10
Current: $1.26
Upside: +693.65%
Jun 17, 2024
Maintains: Buy
Price Target: $90 → $99
Current: $53.82
Upside: +83.95%
May 9, 2024
Maintains: Buy
Price Target: $13 → $14
Current: $1.48
Upside: +845.95%
May 1, 2024
Initiates: Buy
Price Target: $40
Current: $7.81
Upside: +412.16%
Apr 26, 2024
Maintains: Buy
Price Target: $120 → $130
Current: $128.35
Upside: +1.29%
Feb 23, 2024
Maintains: Buy
Price Target: $35 → $55
Current: $44.79
Upside: +22.80%